This is a non-core endpoint: only basic statistics are computed.
Insulin, intermediate and long-acting
INSULIN_INTER_AND_LONG
No definition available.
Endpoint definition
↥392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
1 out of 7 registries used, show all original rules.
21122
Check minimum number of events
21122
Include endpoints None
21122
Remove individuals based on genotype QC
20429
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Insulin, intermediate and long-acting based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 20429 | 8601 | 11828 |
Unadjusted prevalence (%) | 5.42 | 4.08 | 7.11 |
Mean age at first event (years) | 53.54 | 50.88 | 55.48 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: INSULIN_INTER_AND_LONG – Insulin, intermediate and long-acting
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Insulin, intermediate and long-acting
↥Endpoint not on priority list, no data to show.